• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

    1.080 -0.020 (-1.82%)
    Streaming Delayed Price Updated: 10:32 AM EDT, May 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Sunshine Biopharma Inc. - Common stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit ↗
    Via Stocktwits
    News headline image
    Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening ↗
    Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In ↗
    The company launched Niopeg, a biosimilar to Neulasta, designed to reduce the risk of infection in chemotherapy patients. 
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ ↗
    CEO Steve Slilaty stated that the company is aiming to strengthen its presence in Canada’s generic drugs market, valued at $9.4 billion. 
    Via Stocktwits
    News headline image
    Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug ↗
    Its subsidiary launched Everolimus — a generic version of Novartis’ Afinitor — in the Canadian generic prescription drug market. 
    Via Stocktwits
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
    Via Chartmill
    News headline image
    What's going on in today's pre-market session ↗
    As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug ↗
    Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 million. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    US Stock Futures Slip Ahead Of 'Liberation Day' Tariffs Announcement: Expert Points To Uncertainty Amid Higher Risk Premia ↗
    U.S. stock futures slipped on Wednesday after a mixed session on Tuesday. Futures of major benchmark indices were lower in premarket trading. 
    Via Benzinga
    News headline image
    Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024 ↗
    SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    7 F-Rated Growth Stocks to Avoid Right Now: June 2024 ↗
    A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now. 
    Via InvestorPlace
    News headline image
    3 Penny Stocks Ready to Explode Into Dollar Signs by 2028 ↗
    The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit. 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
     
    Via Benzinga
    News headline image
    Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024 ↗
    SBFM stock results show that Sunshine Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save ↗
    Looking for the best meme stocks to sell after the Roaring Kitty rally? These three struggling companies seem to be beyond hope. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.